Robyn Spoon, Elevate’s Founder and CEO shares her recent visit to Indiana Biosciences Research Institute (RBRI)

   I arrived in Beaverton, Oregon in August feisty and fed up with the lack of treatment options for kids with cancer and ready to learn everything I could about exactly what to do to bring new treatments forward for childhood cancer.  Months before this trip to the Children’s Cancer Therapy Development Institute (cc-tdi) for the Wilms/Rhabdo Nanocourse, our son Justin had died from rhabdomyosarcoma (RMS).

Three months into Justin’s treatment for RMS, he ran out of standard of care treatment options.

   The next 2 years and 3 months became a race to find something, anything that might slow down the beast of a cancer he had been diagnosed with.

Joel, Justin’s dad, Elevate’s CFO, and I were shocked to learn that while much has been done to advance the more common adult cancers, our kids had been pretty much left out of the drug prioritization pipeline! 

[Read more on Elevate’s Building Bridges Blog about the cc-tdi visit here.]

    You can only imagine my surprise that I had traveled all the way to Oregon only to meet a fellow Hoosier who is doing amazing work. My energy and passion to reimagine the development of therapies for childhood cancer was matched by Lou Stancato of Indiana Biosciences Research Institute (IBRI) who was also in attendanceI found out during that trip that Lou had spent his life’s work at a major pharmaceutical company in Indiana trying to bring new therapies to life for pediatric cancer, which is a challenging task on any day, but more so within an industry that struggles to find economic sense developing drugs for small populations. Lou was within weeks of retiring from his job and transitioning into a role at IBRI with the hope of being less constrained and more free to fulfill his life goal of bringing hope to this frustrating and devastating situation. With only a handful of drugs approved for childhood cancers in the same time hundreds have been brought into the clinic for adult patients.

   The first chance I had, I headed up to  IBRI in Indianapolis to learn everything I could about IBRI’s mission and Lou’s role. During my late October visit, I had the chance to spend an hour with Alan Palkowitz, PhD (President/CEO of IBRI) to learn about the history of IBRI and the vision he has for the future, including expanding the critical work of this public/private partnership to include pediatric disease, primarily children’s cancers. Lou also introduced me to Michelle Sawyer, CFO of IBRI, who is tasked with maintaining IBRI’s financial health so they can fulfill their mission

  Lou, the Global Leader of the Pediatric Rare Disease Platform for IBRI, is a creative and motivated leader in the therapy development pipeline. Under his leadership, I hope IBRI will be able to be a key player in moving the brilliant ideas stuck in academia over the “valley of death” in therapy development and into the hands of those who need them most, our kids! With 95% of the work in academia stuck in academia, he’s got a big job to do. He’s currently working  piloting the process to expedite the development of new treatments for childhood cancer with one specific new drug. The hope is that if this process can work, then they will have a process in place for other therapies in the future! Bring it on!

   Those who know me, know I can really geek out in a science lab. Needless to say, my inner geek was super excited to spend time in the lab at IBRII could feel the potential for the future all around me!

   Lou has also recently joined the faculty at IU Medical School, which will aid in creating the necessary connections to the critical work being done in academia on behalf of childhood cancer. They just need some help, help to do a job they aren’t equipped to do: bringing the therapies over the finish line into the clinical trials our kids so desperately need!

   Since our meeting, Elevate had the opportunity to sponsor a meeting with Lou for other charitable organizations focused on RMS to help us all become better equipped advocates within therapy development for childhood cancer.

  In order to make a difference, we must become informed advocates.

 

What’s in store for 2024?

Be on the lookout for more collaborations with Lou in this new year! 

 

 

 

 

 

 

 

Indiana Biosciences Research Institute

Applying science to solve complex biomedical problems.

ELEVATE at the FDA

  "      "Making more drugs available to kids with cancer means solving a million small problems. Yesterday’s event provided a necessary opportunity to bring more and more of those problems to light. If we can identify the problems, name the problems, then we can...

Tatum and Maisie Moving Mountains

"The challenges of being a pediatric cancer family are innumerable. Every time you think you’ve found the worst thing, something else rears its ugly head. These past few weeks we’ve witnessed a hefty serving of that humanity, led by two young girls, Tatum Pillor and...

Outwork the Noise

Don’t listen to those voices. Let your hard work, sweat and exertion drown out the noise.  Outwork the noise. -Justin Spoon Outwork the noise means something different for each of us. Robyn Spoon, Elevate Founder shares what this meant to Justin, and what it means to...

A Son, Brother, Collegiate Runner and Asbury Graduate Diagnosed with Rhabdomyosarcoma

"Today, you don't have to do something special. You don't have to do anything amazing or overwhelming. You just gotta get of bed and do something."    - Justin Spoon - A mother's share:     Sitting in a small Lexington, Kentucky clinic room with my then 21-year-old...

Ewings Sarcoma Mom Shares

"Her diagnosis story is probably best classified as ‘trust your gut and ask for the extra tests’."    - Aimee Formo, Ewings Sarcoma Survivor's mom & Childhood Cancer AdvocateGuest Blog by: Aimee Formo    Ewings sarcoma, also abbreviated EWS,  is an aggressive type...

Rhabdomyosarcoma: A Bereaved Mom Shares

Guest Blog by: Cindy Cleveland   Matt Cleveland 2/5/1997-3/8/2023  "From the time Matthew was little, he could most frequently be found playing baseball," Matthew's mom Cindy shares with Elevate.   "His love for the game started with T-Ball at the age of 4, continued...

First Look: Parents Share How They First Discovered Their Child Had Rhabdomyosarcoma

"A small, relatively painless lump near his left nostril had a name- Rhabdomyosarcoma"    - Robyn Spoon, Elevate CEO & Founder    "Rhabdomyosarcoma is rare, with only about 500 total diagnoses in the US each year and only a small percentage of those above the age...

Multi-Stakeholder Engagement for Wilms Tumor that Puts Children in the Center

“Organizing ideas for presentation is one of the best ways to learn. What we learn we can teach. I learned a new concept through working on the poster—design thinking. And learning about this subject was the beginning of teaching it in our role as advocates, a...

Elevate Wilms at the 12th International Pediatric Renal Tumors Biology Meeting

"Five years ago I was sitting across from the oncologists, today, I sit with them."    - C. Comer MTS, BSN, RN,Mike Ortiz, MD and Robyn Spoon, Elevate CEO       Great things that happened in New York to make a difference for Wilms tumor. Elevate Wilms...

Change Starts From the Ground Up

"Elevate provides a space to work towards solutions and a platform to make effective change."    - C. Comer MTS, BSN, RN,Guest Blog by: C. Comer MTS, BSN, RN       In the past, people with a common cause may have had coffee. Today, they zoom or form social media...

@2023 ELEVATE Childhood Cancer Research
and Advocacy, Inc.
is a registered 501(c)(3) non-profit organization.
EIN: 93-2185372

Join us! Stay up to date with our work and mission.

2 + 5 =

Please help keep our site secure and solve this problem.

We respect your privacy and will never sell or share your information.